More Business Wire
View Older Stories View Newer Stories-
Nuvation Bio Announces Data from Pivotal Phase 2 TRUST-I Study of its Investigational ROS1 Inhibitor, Taletrectinib, are Published in the Journal of Clinical Oncology and Reported at 2024 ASCO Annual
-
Ivonescimab Manuscript for HARMONi-A Clinical Trial Results Published in JAMA
-
Gilead and Arcus Announce Anti-TIGIT Domvanalimab Plus Zimberelimab and Chemotherapy Exceeded One Year of Median Progression-Free Survival as a First-Line Treatment for Upper GI Cancers
-
Takeda and Pfizer Announce Four-Year Results from Positive Phase 3 HD21 Trial of Additional ADCETRIS® (brentuximab vedotin) Combination in Frontline Hodgkin Lymphoma
-
Pfizer’s ADCETRIS® Regimen Produces Clinically Meaningful Improvement in Overall Survival in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma (DLBCL)
-
KRAZATI (adagrasib) Demonstrated Statistically Significant Improvement in Progression-Free Survival in Patients with Pretreated Locally Advanced or Metastatic KRASG12C-Mutated Non-Small Cell Lung Canc
-
Massive Bio to Unveil Drug Utilization Optimizer (DUO) at ASCO Annual Meeting 2024
-
Accutar Biotechnology Presents Phase 1 Data of AC699 Monotherapy in Patients with ER+ / HER2- Breast Cancer at ASCO 2024
-
Clariane: Information on the Availability of an Amendment to the 2023 Universal Registration Document
-
AnalytixInsight Reports 2023 Financial Results and Provides MCTO Status Update
-
The Chemours Company Temporarily Pauses Titanium Dioxide Production at Altamira, Mexico Site Amid Severe Regional Drought
-
Generation Mining Files Final Base Shelf Prospectus and Updates Shareholders
-
Tikehau Capital: Disclosure of shares repurchases from 24 May 2024 to 30 May 2024
-
Government Regulation Creates Blue Oceans
-
Inocras Presents Poster for Breast Cancer at 2024 ASCO Annual Meeting, Showing Transformative Impact of WGS-based HRD Testing
-
Leading Independent Proxy Advisory Firm Institutional Shareholder Services Joins Glass Lewis in Recommending Votes “FOR” ALL Nine WisdomTree Board Nominees
-
SABA Announces Notification of Sources of Distributions
-
BRW Announces Notification of Sources of Distributions
-
Ivonescimab in Combination with Chemotherapy Approved in China by NMPA for 2L+ EGFRm NSCLC based on HARMONi-A Clinical Trial: Positive Trend Observed in Overall Survival towards Ivonescimab Plus Che
-
FCPT Announces Acquisition of a Mavis Tire Property for $2.4 Million
-
University of Phoenix and Executive Networks Study on Workplace Well-Being Highlights Challenges of Current Approaches in Addressing Mental Health
-
Drive Shack Inc. Releases Fourth Quarter and Full-Year 2023 Financial Results
-
Capstone Copper Announces Retirement of Robert Gallagher from the Board of Directors
-
Medical Properties Trust Publishes Its Third Annual Corporate Responsibility Report
-
Fonon's Additive Manufacturing Technology To Transform Construction Industry
-
FCPT Announces Acquisition of a National Veterinary Associates Property for $2.0 Million
-
Sarepta Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
-
Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
-
Ventas to Present at Nareit’s REITweek 2024 Investor Conference
-
Korn Ferry Recognized for Seventh Consecutive Year as a Leader in Everest Group’s Recruitment Process Outsourcing (RPO) Services PEAK Matrix® Assessment 2024
-
Boston Omaha Corporation Announces Date for 2024 Annual Meeting of Stockholders
-
Darwin’s Natural Pet Products Continues Ongoing Partnership with PAWS for Annual PAWS Walk
-
Ault Disruptive Technologies Responds to Unusual Market Activity
-
Hope Biosciences Research Foundation Announces Topline Results of Cell Therapy Clinical Trial in Long COVID
-
State Street Corporation (NYSE: STT) Announces Date for Release of Second-Quarter 2024 Financial Results and Conference Call Webcast
-
MedX Health Corp. announces proposed extension of Non-brokered Private Placement offering
-
Certain BlackRock Closed-End Funds Announce Estimated Sources of Distributions
-
UBS Announces Assumption of Three Outstanding Credit Suisse ETNs; Rebranding as “ETRACS”
-
Equity Residential to Participate in Nareit REITweek Conference
-
SITE Centers Declares Second Quarter 2024 Class A Preferred Share Dividend
-
PulteGroup, Inc. Announces Pricing for Tender Offers for Senior Notes
-
Eaton Expands Reach into European Data Center Market by Making Strategic Investment in NordicEPOD
-
Bradley E. Cooper Appointed to Hamilton Board of Directors
-
Emerald to Participate in Maxim Group TMT Conference
-
PGIM Closed End Funds Declare Distributions for June, July and August 2024
-
AvalonBay Communities, Inc. Announces Participation in Nareit’s REITweek Conference, Provides Second Quarter 2024 Operating Update, and Publishes Updated Investor Presentation
-
Pacific Coast Oil Trust Announces There Will Be No May Cash Distribution
-
Camden Property Trust Announces Participation in Nareit’s REITweek 2024 Investor Conference and Provides Second Quarter 2024 Operating Update
-
Westlake Chemical Partners Provides Tax Reporting Information
-
First Trust Advisors L.P. Announces Distribution for Exchange-Traded Funds
